These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22200181)

  • 21. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.
    Jeng JE; Tsai JF; Chuang LY; Ho MS; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
    Neoplasia; 2007 Nov; 9(11):987-92. PubMed ID: 18030367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
    Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
    Yee LJ; Tang J; Herrera J; Kaslow RA; van Leeuwen DJ
    Genes Immun; 2000 Aug; 1(6):386-90. PubMed ID: 11196686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Necrosis Factor-Alpha Gene Polymorphism Associated With Development of Hepatitis B Virus-associated Hepatocellular Carcinoma.
    Jin YJ; Lee D; Chung YH; Kim JA; Kim SE; Lee YS; Shin ES; Ryu SH; Jang MK; Lee JE; Park NH
    J Clin Gastroenterol; 2015 Sep; 49(8):e76-81. PubMed ID: 25319734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
    Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
    Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.
    Corchado S; Márquez M; Montes de Oca M; Romero-Cores P; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2013; 8(6):e66619. PubMed ID: 23840511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
    Senkerikova R; Frankova S; Jirsa M; Kreidlova M; Merta D; Neroldova M; Chmelova K; Spicak J; Sperl J
    PLoS One; 2019; 14(9):e0222609. PubMed ID: 31527889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.
    Teixeira AC; Mendes CT; Marano LA; Deghaide NH; Secaf M; Elias J; Muglia V; Donadi EA; Martinelli AL
    Hum Immunol; 2013 Aug; 74(8):1024-9. PubMed ID: 23632060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
    Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
    Bakr NM; Awad A; A Moustafa E
    IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM; Kandil LS; Nomeir HM; Kandil NS
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 40.  PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.
    Al-Qahtani AA; Al-Anazi MR; Al-Zoghaibi FA; Abdo AA; Sanai FM; Al-Hamoudi WK; Alswat KA; Al-Ashgar HI; Khan MQ; Albenmousa A; Khalak H; Al-Ahdal MN
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):824-833. PubMed ID: 27740515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.